Skip to main content

Dry Skin

0
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
AmLactin® Rapid ReliefN/A1 trial
Active Trials
NCT04085809Completed56Est. Apr 2019
Novartis
NovartisBASEL, Switzerland
1 program
AmLactin® Rapid ReliefN/A
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
Cosmetic product AV0018BN/A1 trial
Active Trials
NCT07271628Completed24Est. Oct 2021
ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
Developmental moisturizing cream 1N/A
GSK
GSKLONDON, United Kingdom
1 program
Developmental moisturizing cream 1N/A1 trial
Active Trials
NCT03804710Completed158Est. Apr 2019
Lacer
LacerSpain - Barcelona
1 program
Repairing creamN/A1 trial
Active Trials
NCT07393191Completed35Est. Apr 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LacerRepairing cream
Pierre FabreCosmetic product AV0018B
SandozAmLactin® Rapid Relief
GSKDevelopmental moisturizing cream 1

Clinical Trials (4)

Total enrollment: 273 patients across 4 trials

NCT07393191LacerRepairing cream

Evaluation of Hydrating Cream Effect on Subjects With Dry Skin.

Start: Dec 2024Est. completion: Apr 202535 patients
N/ACompleted
NCT07271628Pierre FabreCosmetic product AV0018B

Evaluation of the Moisturizing Effect of Study Product AV0018B and the Persistence of This Effect After Repeated Applications, Compared to an Untreated Control Area.

Start: Oct 2021Est. completion: Oct 202124 patients
N/ACompleted
NCT04085809SandozAmLactin® Rapid Relief

This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic

Start: Mar 2019Est. completion: Apr 201956 patients
N/ACompleted
NCT03804710GSKDevelopmental moisturizing cream 1

To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function

Start: Jan 2019Est. completion: Apr 2019158 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.